372 related articles for article (PubMed ID: 26456860)
21. Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin.
Schmeisser F; Friedman R; Besho J; Lugovtsev V; Soto J; Wang W; Weiss C; Williams O; Xie H; Ye Z; Weir JP
Influenza Other Respir Viruses; 2013 May; 7(3):480-90. PubMed ID: 23122228
[TBL] [Abstract][Full Text] [Related]
22. Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice.
Asthagiri Arunkumar G; Ioannou A; Wohlbold TJ; Meade P; Aslam S; Amanat F; Ayllon J; García-Sastre A; Krammer F
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626682
[TBL] [Abstract][Full Text] [Related]
23. A unique and conserved neutralization epitope in H5N1 influenza viruses identified by an antibody against the A/Goose/Guangdong/1/96 hemagglutinin.
Zhu X; Guo YH; Jiang T; Wang YD; Chan KH; Li XF; Yu W; McBride R; Paulson JC; Yuen KY; Qin CF; Che XY; Wilson IA
J Virol; 2013 Dec; 87(23):12619-35. PubMed ID: 24049169
[TBL] [Abstract][Full Text] [Related]
24. How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin.
Doud MB; Lee JM; Bloom JD
Nat Commun; 2018 Apr; 9(1):1386. PubMed ID: 29643370
[TBL] [Abstract][Full Text] [Related]
25. The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency.
Hufton SE; Risley P; Ball CR; Major D; Engelhardt OG; Poole S
PLoS One; 2014; 9(8):e103294. PubMed ID: 25084445
[TBL] [Abstract][Full Text] [Related]
26. Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin.
Laursen NS; Friesen RHE; Zhu X; Jongeneelen M; Blokland S; Vermond J; van Eijgen A; Tang C; van Diepen H; Obmolova G; van der Neut Kolfschoten M; Zuijdgeest D; Straetemans R; Hoffman RMB; Nieusma T; Pallesen J; Turner HL; Bernard SM; Ward AB; Luo J; Poon LLM; Tretiakova AP; Wilson JM; Limberis MP; Vogels R; Brandenburg B; Kolkman JA; Wilson IA
Science; 2018 Nov; 362(6414):598-602. PubMed ID: 30385580
[TBL] [Abstract][Full Text] [Related]
27. Neutralizing antibody PR8-23 targets the footprint of the sialoglycan receptor binding site of H1N1 hemagglutinin.
Yan L; Sun L; Guo C; Li L; Sun J; Huang X; Zhao P; Xie X; Hu J
J Med Virol; 2021 Jun; 93(6):3508-3515. PubMed ID: 33410516
[TBL] [Abstract][Full Text] [Related]
28. Development of neutralizing monoclonal antibodies against the pandemic H1N1 virus (2009) using plasmid DNA immunogen.
Cabral TM; Baig A; Berhane Y; Schmidt L; Hole K; Leith M; Kobasa D; Corbett CR
J Virol Methods; 2014 Jan; 195():54-62. PubMed ID: 24060631
[TBL] [Abstract][Full Text] [Related]
29. A cross-clade H5N1 influenza A virus neutralizing monoclonal antibody binds to a novel epitope within the vestigial esterase domain of hemagglutinin.
Paul SS; Mok CK; Mak TM; Ng OW; Aboagye JO; Wohlbold TJ; Krammer F; Tan YJ
Antiviral Res; 2017 Aug; 144():299-310. PubMed ID: 28633988
[TBL] [Abstract][Full Text] [Related]
30. Human monoclonal antibodies neutralizing influenza virus A/H1N1pdm09 and seasonal A/H1N1 strains - Distinct Ig gene repertoires with a similar action mechanism.
Hiroi S; Kuhara M; Kishi Y; Ono KI; Matsuzawa S; Yamamoto N; Komano J
Immunobiology; 2018 Mar; 223(3):319-326. PubMed ID: 29107382
[TBL] [Abstract][Full Text] [Related]
31. Cross-neutralization of influenza A viruses mediated by a single antibody loop.
Ekiert DC; Kashyap AK; Steel J; Rubrum A; Bhabha G; Khayat R; Lee JH; Dillon MA; O'Neil RE; Faynboym AM; Horowitz M; Horowitz L; Ward AB; Palese P; Webby R; Lerner RA; Bhatt RR; Wilson IA
Nature; 2012 Sep; 489(7417):526-32. PubMed ID: 22982990
[TBL] [Abstract][Full Text] [Related]
32. Divergent Requirement of Fc-Fcγ Receptor Interactions for
Wang S; Ren H; Jiang W; Chen H; Hu H; Chen Z; Zhou P
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331095
[TBL] [Abstract][Full Text] [Related]
33. Antibody 27F3 Broadly Targets Influenza A Group 1 and 2 Hemagglutinins through a Further Variation in V
Lang S; Xie J; Zhu X; Wu NC; Lerner RA; Wilson IA
Cell Rep; 2017 Sep; 20(12):2935-2943. PubMed ID: 28930686
[TBL] [Abstract][Full Text] [Related]
34. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.
Xu R; Ekiert DC; Krause JC; Hai R; Crowe JE; Wilson IA
Science; 2010 Apr; 328(5976):357-60. PubMed ID: 20339031
[TBL] [Abstract][Full Text] [Related]
35. Broadly neutralizing antibodies against influenza viruses.
Laursen NS; Wilson IA
Antiviral Res; 2013 Jun; 98(3):476-83. PubMed ID: 23583287
[TBL] [Abstract][Full Text] [Related]
36. A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses.
Shen C; Chen J; Li R; Zhang M; Wang G; Stegalkina S; Zhang L; Chen J; Cao J; Bi X; Anderson SF; Alefantis T; Zhang M; Cai X; Yang K; Zheng Q; Fang M; Yu H; Luo W; Zheng Z; Yuan Q; Zhang J; Wai-Kuo Shih J; Kleanthous H; Chen H; Chen Y; Xia N
Sci Transl Med; 2017 Oct; 9(412):. PubMed ID: 29046433
[TBL] [Abstract][Full Text] [Related]
37. Naturally occurring antibodies in humans can neutralize a variety of influenza virus strains, including H3, H1, H2, and H5.
Ohshima N; Iba Y; Kubota-Koketsu R; Asano Y; Okuno Y; Kurosawa Y
J Virol; 2011 Nov; 85(21):11048-57. PubMed ID: 21865387
[TBL] [Abstract][Full Text] [Related]
38. Epitope mapping of neutralizing monoclonal antibody in avian influenza A H5N1 virus hemagglutinin.
Ohkura T; Kikuchi Y; Kono N; Itamura S; Komase K; Momose F; Morikawa Y
Biochem Biophys Res Commun; 2012 Feb; 418(1):38-43. PubMed ID: 22226969
[TBL] [Abstract][Full Text] [Related]
39. Structural Insights into Reovirus σ1 Interactions with Two Neutralizing Antibodies.
Dietrich MH; Ogden KM; Katen SP; Reiss K; Sutherland DM; Carnahan RH; Goff M; Cooper T; Dermody TS; Stehle T
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928010
[TBL] [Abstract][Full Text] [Related]
40. Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A Viruses.
Chuang GY; Shen CH; Cheung CS; Gorman J; Creanga A; Joyce MG; Leung K; Rawi R; Wang L; Yang ES; Yang Y; Zhang B; Zhang Y; Kanekiyo M; Zhou T; DeKosky BJ; Graham BS; Mascola JR; Kwong PD
Front Immunol; 2021; 12():662909. PubMed ID: 34135892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
